Camden Capital, LLC Dexcom Inc Transaction History

Camden Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $214,276 - $262,827	-1,876 Reduced 51.61%	1,759 $243,000
Q4 2023 Feb 05, 2024	BUY	$75.49 - $124.16 $274,406 - $451,321	3,635 New	3,635 $451,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $152,199 - $219,701	1,791 New	1,791 $202,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Camden Capital, LLC with notifications on news.